Sold Out
Book Categories |
Preface | ||
Sponsors | ||
List of Participants | ||
Pt. I | Introduction to Disease Markers in Exhaled Breath | |
Sect. 1 | Nitric Oxide | |
Regulation of Nitric Oxide Synthases in the Lung | 3 | |
Nitric Oxide Production in the Lung and its Regulation by Oxygen | 11 | |
S-Nitrosothiols in Respiratory Biology | 18 | |
Inhibitors of Nitric Oxide Synthase: Experimental Findings and Clinical Implications | 24 | |
Inhaled NO as a Replacement Therapy | 30 | |
Physiology of Exhaled Nitric Oxide | 35 | |
The "Vascular" Origins of Exhaled Nitric Oxide | 49 | |
Exhaled NO originates in Airway Epithelium | 52 | |
NO is Generated via NOS Enzymes | 57 | |
Technical Aspects of Exhaled NO: Investigator Point of View | 62 | |
Technical Aspects of Exhaled Nitric Oxide: Aerocrine Point of View | 64 | |
Sect. 2 | Carbon Monoxide | |
Cytoprotection by Heme Oxygenase / CO in the Lung | 73 | |
Role of Heme Oxygenase in Airway Smooth Muscle Contractility | 79 | |
Exhaled Carbon Monoxide is Produced in the Lungs | 84 | |
Exhaled Carbon Monoxide is Delivered from Systemic Sources | 88 | |
Kinetics of Carbon Monoxide Accumulation in Exhaled Breath | 93 | |
ETCOc: An Indicator of Hemolysis in Neonatal Hyperbilirubinemia | 96 | |
Sect. 3 | Volatile Organic Compounds (VOCs) | |
Volatile Organic Compounds as Exposure Markers | 105 | |
Volatile Organic Compounds as Markers in Normal and Diseased States | 113 | |
Sect. 4 | The "Living State" | |
The Living State: Intimate Insights through Personal Discoveries | 125 | |
Pt. II | Asthma | |
Biology of Asthma | 133 | |
Transcriptional Regulation of Airway Inflammation | 143 | |
Molecular Mechanisms of Steroid Actions | 151 | |
Nitric Oxide Reactions in the Asthmatic Airway | 159 | |
Regulation of pH in the Human Airway: Mechanisms and Monitoring | 167 | |
Markers in Exhaled Air and Condensate to Monitor Treatment in Asthma | 177 | |
Extended NO Analysis Applied to Patients with Known Altered Values of Exhaled NO | 187 | |
Exhaled Nitric Oxide and Atopy | 191 | |
Bradykinin and Exhaled Nitric Oxide in Asthma | 196 | |
Exhaled NO is an Optimal Marker of Severity and Responsiveness to Therapy in Asthma | 199 | |
Superoxide-NO Interactions in Paranasal Sinus Inflammatory Diseases | 202 | |
Pt. III | Chronic Lung Diseases | |
Biology, Diagnosis and Management of COPD | 209 | |
Disease Markers in COPD: Exhaled Breath vs. Exhaled Condensate | 218 | |
The Biology of Cystic Fibrosis | 223 | |
Exhaled Markers in Cystic Fibrosis | 234 | |
Lung Cancer Screening by Breath Analysis | 242 | |
Nitric Oxide and Rheumatic Diseases | 246 | |
Nitric Oxide in Hepatopulmonary Syndrome | 257 | |
Pathological Changes in the Airways Epithelium of Liquidators of the Chernobyl Catastrophe | 261 | |
Pt. IV | Transplantation | |
Heme Oxygenase-1 and/or Carbon Monoxide can Promote Organ Graft Survival | 267 | |
Mechanisms of and Clinical Efforts to Minimise Perioperative Lung Injury | 274 | |
Condensate Inflammatory Markers in Lung Transplantation | 284 | |
Exhaled Nitric Oxide (NO) in Human Lung Ischemia-Reperfusion | 291 | |
In Situ Lung Autotransplantation Model in Pigs | 300 | |
Pathogenetic Mechanisms Leading to Obliterative Bronchiolitis | 304 | |
Pt. V | ARDS and Oxidative Stress | |
Clinical Pathology of ARDS | 319 | |
Markers of Oxidative Stress in Exhaled Breath Condensate | 333 | |
Volatile Organic Compounds as Prognostic Markers in ARDS | 338 | |
Do Reactive Oxygen-Nitrogen Intermediates Contribute to the Pathogenesis of ARDS? | 344 | |
Modulation of Active Alveolar Na[superscript +] Transport by Reactive Oxygen-Nitrogen Intermediates | 354 | |
Luteolin Reduces LPS-Induced TNF-[alpha] Production and Protects Mice against LPS Toxicity | 366 | |
Acute Lung Injury in the Setting of Cardiopulmonary Bypass | 369 | |
Oxidative Stress During Cardiac Surgery in Diabetic Patients | 375 | |
Pt. VI | New Technological Developments | |
Exhaled Breath Condensate | 383 | |
Smell as a Diagnostic Tool in the 21st Century: The Portable Electronic Nose | 387 | |
Biosensors and Express Biochemical Diagnostics of Some Diseases | 391 | |
Infrared Laser Spectrometer for Real-Time Analysis of Ethane in Exhaled Human Breath | 395 | |
Methods of Tuneable Diode Laser Absorption Spectroscopy Applied to the Analysis of Exhaled Breath | 400 | |
Pt. VII | Industrial Forum | |
Industrial Forum - Aerocrine AB | 407 | |
Biochemical Diagnostics of the Lung with ECoScreen | 410 | |
Portability and Flexibility in Exhaled Breath Condensate Collection | 413 | |
Author Index | 417 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionDisease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications, Vol. 346
X
This Item is in Your InventoryDisease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications, Vol. 346
X
You must be logged in to review the productsX
X
X
Add Disease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications, Vol. 346, Approximately 60 papers from the June 2001 conference in Crete discuss disease markers and specific disorders, with particular attention to nitric oxide, carbon monoxide, volatile organic compounds, asthma, chronic lung diseases, transplantations, ARDS an, Disease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications, Vol. 346 to the inventory that you are selling on WonderClubX
X
Add Disease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications, Vol. 346, Approximately 60 papers from the June 2001 conference in Crete discuss disease markers and specific disorders, with particular attention to nitric oxide, carbon monoxide, volatile organic compounds, asthma, chronic lung diseases, transplantations, ARDS an, Disease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications, Vol. 346 to your collection on WonderClub |